Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
OTCMKTS:CBIS

Cannabis Science (CBIS) Stock Price, News & Analysis

Cannabis Science logo

About Cannabis Science Stock (OTCMKTS:CBIS)

Advanced Chart
Remove Ads

Key Stats

Today's Range
$0.0050
$0.0050
50-Day Range
$0.0050
$0.0050
52-Week Range
$0.00
$0.06
Volume
N/A
Average Volume
4.85 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Cannabis Science, Inc., together with its subsidiaries, develops, produces, and commercializes phytocannabinoid-based pharmaceutical products primarily in the United States. The company is developing medicines for autism, blood pressure, cancer, cancer side effects, and other illnesses, as well as for general health maintenance. Its drugs under development include CS-TATI-1 for newly diagnosed and treatment-experienced patients with drug-resistant HIV strains, as well as those intolerant of available therapies; CS-S/BCC-1 to treat basal and squamous cell carcinomas; and a proprietary cannabis-based therapy for neurological conditions. In addition, the company offers an online video-based medical cannabis education system, including courses, such as medical cannabis law, benefits of medical marijuana, cooking, horticulture, and bud tending; and manufactures and distributes specialty horse and pet grooming and topical applications. It has collaboration with IGXBio, Inc. to develop GenePro, a DNA-based immunotherapeutic drug; and a research collaboration agreement with Dana-Farber Cancer Institute, Inc. to develop and investigate the use of cannabinoids to cure various cancers, as well as with Stellenbosch University to treat chronic pelvic pain associated with pelvic inflammatory disease in women, chronic prostatitis in men, and other chronic pain associated with other indications. The company was formerly known as Gulf Onshore, Inc. and changed its name to Cannabis Science, Inc. in April 2009. The company was incorporated in 1996 and is based in Irvine, California. Cannabis Science, Inc. is a subsidiary of Weedmaps Media, Inc.

Remove Ads
Receive CBIS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Cannabis Science and its competitors with MarketBeat's FREE daily newsletter.

CBIS Stock News Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.
See More Headlines

CBIS Stock Analysis - Frequently Asked Questions

Cannabis Science Inc (OTCMKTS:CBIS) posted its quarterly earnings results on Tuesday, July, 28th. The company reported $0.00 EPS for the quarter.

Based on aggregate information from My MarketBeat watchlists, some other companies that Cannabis Science investors own include Medical Marijuana (MJNA), Hemp (HEMP), Canopy Growth (CGC), NVIDIA (NVDA), 22nd Century Group (XXII), Unrivaled Brands (TRTC) and Micron Technology (MU).

Company Calendar

Last Earnings
7/28/2015
Today
3/30/2025

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
Cannabis
Current Symbol
OTCMKTS:CBIS
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Price / Cash Flow
N/A
Price / Book
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
The 10 Best AI Stocks to Own in 2025 Cover

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

This page (OTCMKTS:CBIS) was last updated on 3/30/2025 by MarketBeat.com Staff
From Our Partners